Premium
Failure rate: Why many cancer drugs don't receive FDA approval, and what can be done about it
Author(s) -
Printz Carrie
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28994
Subject(s) - medicine , drug approval , cancer drugs , clinical research , cancer , family medicine , drug , pharmacology